Skip to content

An observational study to assess tubal patency in infertile women with Hycosy by using the Ultrasound contrast agent lignosal

Hycosy(Hysterosalpingocontrastsonography) by using the Ultrasound contrast agent lignosal (mixture of 2% lignocaine jelly and saline) for the evaluation of tubal patency in infertile women an observational study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/05/013783
Enrollment
60
Registered
2018-05-09
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Women referred for Hycosy(Hysterosalpingo contrast sonography)

Interventions

Intervention1: Lignocaine 2% w/v gel mixed with normal saline contrast medium: Lignocaine 2% w/v gel mixed with normal saline contrast medium Control Intervention1: NIL: NIL

Sponsors

Dr Ch V Narayana Rao
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Participants willing to sign an Informed Consent Form indicating that they understand the purpose of and the procedures required for the study and are willing to participate in it. 2)Female patients of child bearing age, 18 - 50 years of age who are referred to the Study site to undergo Tubal Patency Test using HyCoSy (Hysterosalpingo Contrast Sonography) procedure.

Exclusion criteria

Exclusion criteria: 1)Patients with known allergy to the ingredients of the contrast medium. 2)Pregnant or breast-feeding women 3)Presence of any other clinically significant disease or laboratory findings that in the Investigator opinion may affect efficacy or safety assessments. 4)History of alcohol or drug abuse, or suspicion thereof in the Investigator judgment. 5)History of or active hepatitis B or C within the past 3 months or history of HIV infection. 6)History of seizure disorder or epilepsy

Design outcomes

Secondary

MeasureTime frame
Safety of Lignocaine 2% w/v gel mixed with normal saline contrast mediumTimepoint: 1 Day

Primary

MeasureTime frame
Effectiveness of Lignocaine 2% w/v gel mixed with normal saline contrast mediumTimepoint: 1 Day

Countries

India

Contacts

Public ContactDr Ch V Narayana Rao

Shilpa Scan Center

chnr42@yahoo.com9849611266

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026